Omnes Capital's exits

Filters
Display:
Sector 
Business services
Entry Date 
2013
Exit Date 
2019
Buyer 
Verlingue
Business 
Small-Cap Buyout & Growth Capital

Groupe Eyssautier

www.groupe-eyssautier.com
France’s leading marine and transport insurance broker

Founded by the Eyssautier family in 1935, the group is now the leading marine and transport insurance broker in the French market. It covers the entire spectrum of shipping and transport insurance activities (risk analysis, negotiation and placement of cover with insurers, policy management, claims handling and recovery actions on behalf of policyholders, etc.).

Latest news
19/09/2019
Omnes sells Eyssautier Group to insurance broker Verlingue
Read the press release
6141
Sector 
Business services
Entry Date 
2013
Exit Date 
2019
Buyer 
Management (LBO led by BPI et Siparex)
Business 
Small-Cap Buyout & Growth Capital

Camerus

www.camerus.fr
Specialist in furniture rental for events
Camérus is specialised in the rental of furniture for organisers, exhibitors and decorators at trade fairs, seminars and conferences. The company has built its business around five key pillars: selection of modern and designer furniture meeting customer expectations, creation of its own furniture in response to specific customer requests, management and servicing of all the furniture in storage, transfer by truck of furniture to trade fairs, and retrieval of furniture from customer stands.
Sector 
Medical devices
Entry Date 
2006
Exit Date 
2019
Business 
Venture Capital
Sales 
€16.9 million in FY 2013

SuperSonic Imagine

www.supersonicimagine.fr
UltraFast™ revolutionary ultrasound system for medical imaging

Founded in 2005 and headquartered in Aix-en-Provence (France), SuperSonic Imagine is a medical imaging specialist. The company has designed, developed and markets Aixplorer®, a next-generation ultrasound platform harnessing UltraFast™ technology at a data acquisition rate around 200 times faster than that of rival systems. Aixplorer® is the only ultrasound system able to image two types of waves: ultrasound waves to ensure impeccable quality; and shearwaves to measure and display in real time tissue elasticity using a reliable, replicable and non-invasive procedure. ShearWave™ Elastography helps to detect and characterise multiple conditions in numerous applications and in particular breast, thyroid, liver and prostate scans.

Sector 
SaaS / Cloud
Entry Date 
2018
Exit Date 
2019
Buyer 
Cisco
Business 
Venture Capital

Sentryo

sentryo.net
Pioneer of Industrial Internet cybersecurity solutions
Sentryo helps organizations embrace the promises of Industry 4.0 innovations by keeping their industrial operations safe from cyber-attacks. Sentryo’s ICS CyberVision award winning platform gives control engineers comprehensive visibility on their industrial control systems, detects anomalies and accelerates response to cybersecurity incidents keeping them ahead of cyber threats.
Latest news
03/12/2018
Sentryo raises a new round of €10M
Read the press release
5790
Sector 
Business services
Entry Date 
2012
Exit Date 
2019
Buyer 
Management
Business 
Small-Cap Buyout & Growth Capital

e-Frontech

www.efrontech.com
CRM and BI application service companies

Founded in 2000, e-Frontech is an IT consulting and service company specialised in the integration of Oracle’s Customer Relationship Management (CRM) and Business Intelligence applications. The group supports its customers over the long term by offering them a full range of expertise, consulting, functional assistance and integration services to manage the entire life cycle of their Oracle CRM and BI applications. As a longstanding Oracle partner, e-Frontech has established itself among the leading players in the sector.

Latest news
09/02/2012
Crédit Agricole Private Equity invests in e-Frontech alongside Edith Letournel who is acquiring the company
Read the press release
887
Sector 
Infrastructure
Entry Date 
2010
Exit Date 
2018
Business 
Renewable Energy

Neoen

www.neoen.com/en
International leading Independent power producer

Neoen is a French leading and one of the world’s largest independent power producers of renewable energy. The company was founded in 2008 by Jacques Veyrat. Neoen develops, finances, builds and operates power plants running on renewable energy sources (solar, wind, biomass). Neoen’s footprint extends across 12 countries, including France, Portugal, Australia, Mexico and Egypt. The company aims to achieve a capacity in operation and under construction in excess of 5 GW by 2021.

In October 2018 Neoen entered the regulated market of Euronext Paris and its IPO presented the largest capital raise in the last 16 months on Euronext Paris.

Neoen has been accompanied by Capenergie 1, Capenergie 2 and Capenergie 3.

Latest news
16/10/2018
Success of Neoen’s initial public offering on Euronext Paris
Read the press release
6067
Read the business case
“You are not born an entrepreneur – you become one!"
BARBARO
XAVIER
CEO
of Neoen
> Read more
Neoen
Project

A pioneer spirit

Less than a year after Neoen was set up, Xavier opened up the company to outside investors. He knew that to have staying power, a firm needs to quickly reach critical mass, build professionalism and take emerging international opportunities.

“We chose partners – Louis Dreyfus (now Impala) and Omnes Capital – who shared our vision and mindset. Like us, they are pioneers, and we are so pleased to share this adventure with them.”

PROFILE
Xavier
BARBARO
CEO
of Neoen
“You are not born an entrepreneur – you become one”, says Xavier Barbaro when asked about the success story that is Neoen, which has grown to become France’s third-largest producer of green energy behind EDF and GDF Suez. Admittedly, when he started out, Xavier did have a few important qualities, not least being a graduate of École Polytechnique and École des Ponts et Chaussées, two prestigious French schools. But there was no hint of his future career as an entrepreneur. He got the bug from Jacques Veyrat, then boss of LDCom. “I was deeply marked by my time at LDCom during the dot-com boom. I saw the beating heart of a business and encountered stories of passion, struggle and survival.”
After a spell in the USA, during which he earned an MBA from Harvard Business School, Xavier Barbaro joined Louis Dreyfus Commodities and led a number of projects in Asia, particularly in the biofuel sector. In 2007, he went back to Jacques Veyrat, who was by then in charge of the Louis Dreyfus Group, and told him that he wanted to work in the energy sector and to take on an entrepreneurial project. With Veyrat’s backing, he got involved in renewable energy with the creation of Neoen. It was a daring undertaking in a sector that then included about 300 firms in France. Xavier put his faith in a pioneering spirit, support from top-tier shareholders and a rigorous approach.
Success came quickly. “We now manage projects that are 600 times larger than the ones we started out with in 2008. The launch of Europe’s biggest solar park shows how far we have come in a few years.” Although he is keeping both feet firmly in France, Xavier is also looking abroad, with numerous projects under development in places as far afield as Australia, Egypt, Mexico and El Salvador. “As the costs of producing solar power tumble, we are taking everyone by surprise. This is just beginning.”
CAREER PATH

Timeline

2001: Started out at LDCom, now Neuf Cegetel
2008: Formation of Neoen, initially as part of Direct Energie. Neoen became fully independent in 2011.
2014: Moved up the next level by launching Europe’s largest photovoltaic park in Cestas near Bordeaux and winning two major tenders in El Salvador and Australia. Also the year when Neoen became the third-largest producer of renewable energy in France.

PROJECTPROFILEPATH
neoen
Sector 
Pharma
Entry Date 
2009
Exit Date 
2018
Business 
Venture Capital

arGEN-X

www.argen-x.com
A new antibody platform targeting the treatment of cancer and autoimmune conditions

arGEN-X is a research-stage biopharmaceutical company with a broadly applicable, proprietary platform called SIMPLE Antibody™. Using this platform, arGEN-X is able to create a wide range of monoclonal antibody leads against a broad range of human disease targets. These antibodies are then given highly competitive properties using other technologies in many cases. The company has proven the benefits of its monoclonal antibody development platform by signing numerous partnerships and pursuing two proprietary clinical programmes.

Latest news
09/07/2014
Successful IPO for arGEN-X, a Dutch biopharmaceuticals company supported by Omnes Capital since 2009
Read the press release
960
Sector 
Hardware
Entry Date 
2015
Exit Date 
2018
Buyer 
VYV
Business 
Venture Capital

seniorAdom

https://www.senioradom.com
SeniorAdom offers new remote assistance technology

Founded in November 2012, SeniorAdom offers new remote assistance technology. SeniorAdom’s next-generation technology automatically detects falls and sudden illness using a smart system of detectors (no cameras) connected to a central device. This central device is easy to install and use. It can simply be plugged into a power socket (no need for an internet connection because it has an embedded GSM mobile phone card). No special training is required.
In addition to falls and sudden illness, SeniorAdom’s solution can also report any unusual patterns in the life of a dependent person by sending a text or email to their carer. Each carer has a personalised and secure space from which they can monitor the well-being of the person living in their own home. SeniorAdom has genuinely disrupted the remote assistance space, which had barely advanced in 35 years. It provides comfort and peace of mind to both carers and service users.

Read the business case
« Omnes provides us with its network and helps us to confirm our market credibility »
THIERRY
ROUSSEL
co-founder
of SeniorAdom
> Read more
SeniorAdom

SeniorAdom sets out to conquer the telecare market.

Determined to revolutionise the sector through innovative technology, the start-up has been supported by Omnes Capital and four other reputed investors since 2015

key figures

  • Over 1.5 million seniors or disabled people live at home alone and want to remain autonomous.
  • 47% of seniors take a fall at least once a year, and half of them cannot get back on their feet by themselves.
  • Only 6% of French people over 80 were equipped with smart telecare devices in 2010.
  • Nearly 1,000 people are already equipped with SeniorAdom technology just a few months after commercial launch.
A TELECARE REVOLUTION

The solutions available until now required them to wear a "smart" necklace, watch or bracelet to alert the emergency services in the event of a fall. But these devices are rarely used because they come with a certain stigma and are seen as ineffective in cases of loss of consciousness. In response, SeniorAdom has developed an innovative technology able to automatically detect abnormal situations.


The concept consists of a box connected to sensors that detect the movements of the individual at home and serve to model their habitual everyday movements. In the event of an anomaly, an alarm is sent to the caregivers and then to a call platform, which calls out the emergency services where necessary. « Since its launch in 2012, SeniorAdom has successfully demonstrated the effectiveness of its technology as well as the strong acceptability of the product from both a financial and an everyday use standpoint, » says François-Xavier Dedde, Principal at Omnes Capital. All of which convinced Omnes Capital to invest in the start-up in 2015, with a view to helping it step up the roll-out of its product and extend its distribution platforms. « Acquiring a share in SeniorAdom fits in perfectly with our investment strategy on smart healthcare, » says François-Xavier Dedde. « SeniorAdom brings together all the key success factors: market opportunity, robust technology and a profile of outstanding entrepreneurs »

STRATEGIC PARTNERSHIPS
After admitting Business Angels and Kima Ventures into its capital in mid-2014, the founders initiated a new fundraising in summer 2015, attracting three new investors alongside Omnes Capital : 123Venture, SEB Alliance and AG2R LA MONDIALE. « After leading the financing round, we are supporting the company through regular dialogue with its managers. Our aim is to help them call themselves into question, prioritise, and to offer the benefit of our operational expertise,» says François-Xavier Dedde. The company continues to grow and hopes to expand internationally in the near future.
3 questions for THIERRY ROUSSEL
Thierry
ROUSSEL
co-founder
of SeniorAdom
Why the fundraising in 2015?
After winning a contract with the City of Paris in 2013, SeniorAdom was able to test its solution with vulnerable individuals through the financial support of Business Angels, including Xavier Niel via Kima. A year later, we finally received approval from France’s old-age insurance fund, CNAV. The time had come for us to join forces with investors to initiate the project’s roll-out phase. The investors included financial partners such as 123Venture and Omnes, which I had the pleasure of working with during Direct Energie’s second financing round in 2004, together with manufacturers such as SEB Alliance, which is interested in our technology (the box is a real hub), and AG2R LA MONDIALE, the leader in social protection in France.
What did Omnes Capital contribute to you and your company?
Their contribution was invaluable on several levels. Omnes immediately took charge of the financing round, lending it impetus and challenging our business model. We also benefited from their network, met with robust players, and confirmed our credibility in the market. In addition, we appreciate the quality of the human relations we have with our contacts and their sound understanding of our business.
What are your objectives now?
We have given ourselves a few months to conclude our tests of the various distribution platforms. We recently formed a partnership with Europ Assistance. We need a little more time to gain the necessary perspective and finalise our strategy. We will then organise a new fundraising to initiate international roll-out by harnessing the most relevant platforms.
New-generation telecareA TELECARE REVOLUTIONSTRATEGIC PARTNERSHIPS3 questions for...
senioradom
Sector 
Business services
Entry Date 
2015
Exit Date 
2018
Business 
Mid-Cap Buyout & Growth Capital

Bimedia

www.bimedia.com.fr
One of France’s leading providers of software solutions for local retailers

Founded in La Roche-sur-Yon (Vendée department) in 2002, Bimedia provides software solutions and point-of-sale terminals to almost 6,000 local retailers (newsagents, tobacconists, bakers). Other key strengths of the company include telephony sales, electronic payment systems and digital advertising sales across its network.

Sector 
Medical devices
Entry Date 
2011
Exit Date 
2018
Business 
Venture Capital

Novate Medical

An innovative new inferior vena cava filter device to prevent pulmonary embolism

Based in Galway (Ireland), Novate Medical specialises in developing vena cava filters.
Its flagship product, a bioconvertible vena cava filter, is the first of its kind in the world. It is composed of a bioabsorbable material that helps to protect patients at transient high risk of pulmonary embolism. This medical device dispenses with the need for a follow-up procedure to remove the filter, as required for the optional vena cava filters currently available on the market.

 

Latest news
20/05/2011
Crédit Agricole Private Equity and Seroba Kernel Life Sciences filter an €8.7 million investment into Novate Medical Ltd
Read the press release
848

Pages

NewsRoom
Filters
Display:
Press release
17 March 2021
Artifakt raises 3.7 million euros to make the Web more efficient and agile
Artifakt raises 3.7 million euros to make the Web more efficient and agile
Le Cercle Omnes des Entrepreneurs - January 31, 2018
Publication
Scope, the Omnes Review, July 2020
https://scope.omnescapital.com
Press release
16 December 2020
New primary LBO deal for Omnes and its small cap funds with regional operator Tennaxia, a publisher of SaaS solutions to help listed companies and SMEs / mid-market companies in France with their CSR strategies
New primary LBO deal for Omnes and its small cap funds with regional operator Tennaxia, a publisher of SaaS solutions to help listed companies and SMEs / mid-market companies in France with their CSR strategies
3 minutes for innovation - FCPI innovation funds : Omnes' new investments
Press release
24 November 2020
AlgoTherapeutix raises €12M to take ATX01 into clinical development in chemotherapy-induced peripheral neuropathy
AlgoTherapeutix raises €12M to take ATX01 into clinical development in chemotherapy-induced peripheral neuropathy
Press release
09 November 2020
Omnes makes its first investment in the Irish renewables market, teaming up with solar PV developer Power Capital Renewable Energy
Omnes makes its first investment in the Irish renewables market, teaming up with solar PV developer Power Capital Renewable Energy

Pages